Journal article

PIK3CA Mutations Are Associated With Lower Rates of Pathologic Complete Response to Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy in Primary HER2-Overexpressing Breast Cancer

Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai, Dirk M Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A Fasching, Fabrice Andre, Judith L Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo Show all

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2014